Device Radial Access Guide Sheath

Sublime Radial Access Guide Sheath

Payments companies reported to CMS as associated with Sublime Radial Access Guide Sheath. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$53Kassociated payments (2023-2025)
667clinicians with associated payments
1company reporting

By year

2023 $39K
2024 $14K

Payments reported as associated with Sublime Radial Access Guide Sheath, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $22K
Vascular Surgery $13K
Cardiovascular Disease $4,193
Vascular & Interventional Radiology $2,386
Physician Assistant $1,827
Diagnostic Radiology $1,470

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Sublime Radial Access Guide Sheath

These are the largest totals companies reported as associated with Sublime Radial Access Guide Sheath. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Pradeep Nair Houma, LA Interventional Cardiology $6,691.42
Ankur Lodha Lafayette, LA Interventional Cardiology $5,012.53
Paul Michael Sebring, FL Interventional Cardiology $1,445.72
Amy Coulter Rochester, NY Vascular Surgery $1,173.60
Dean Ferrera East Chicago, IN Interventional Cardiology $1,040.06
Gary Ansel Columbus, OH Interventional Cardiology $873.31
Lucas Ferrer Cardona San Antonio, TX Vascular Surgery $786.24
Anish Thomas Saint Louis, MO Interventional Cardiology $750.00
Peter Schneider Honolulu, HI Vascular Surgery $697.81
Amit Srivastava Edgewood, KY Interventional Cardiology $622.97

Prescribed Sublime Radial Access Guide Sheath?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.